The key is finding what feels sustainable for your real life, not what looks good on paper
Semaglutide trials (STEP 1-4) demonstrated 15-22% weight loss over 68 weeks, while tirzepatide (SURMOUNT trials) showed 20-24% weight loss at the highest doses
daily liraglutide on body weight in adults with overweight or obesity without diabetes: The STEP 8 randomized clinical trial
A good candidate typically includes: Adults who have struggled to achieve or maintain meaningful weight loss through diet and exercise alone Individuals with weight-related health concerns such as high blood sugar, elevated cholesterol, or metabolic slowdown People who prefer a medically supervised, structured approach over self-directed programs Those who are committed to follow-through and regular provider check-ins Individuals looking to complement other aesthetic goals such as skin tightening or body contouring with overall fat reduction The best way to find out if you qualify is through an initial consultation with a Novuskin provider
Vous pouvez galement contacter l'autorit de contrle de l'tat membre de l'UE dans lequel vous rsidez, travaillez ou dans lequel la violation prsume a eu lieu
In the TRIUMPH-1 Phase 3 trial, participants on the maximum dose of retatrutide (12 mg) lost an average of 28.3% of their body weight after 80 weeks, and up to 30.3% after 104 weeks in the study extension
